Opioid Agonist Therapy Adherence Trajectories Among Commercially and Publicly Insured People Living With Hepatitis C in the United States.

ABSTRACT:

Background

Hepatitis C virus (HCV) infection is a public health concern, with people living with opioid use disorder having a higher risk of infection. Despite the cooccurrence of HCV and opioid use disorder, little is known about the treatment patterns for the disorder in this population. This study characterized opioid agonist therapy adherence trajectories over 15 months following opioid agonist therapy initiation among people living with HCV and opioid use disorder and described the baseline characteristics of the patients within distinct opioid agonist therapy adherence trajectories.

Methods

We used Merative MarketScan healthcare claims data from 2015 to 2019 to identify distinct medication treatment adherence trajectories via growth mixture modeling among 5,495 people

SUBMITTER: Psaras C 

PROVIDER: S-EPMC12721478 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature